Repurposing losartan for fibrostenosing Crohn’s disease: a compelling preclinical rationale

• by Luca Massimino, Virginia Solitano, Federica Ungaro

• September 23, 2025

Advanced Crohn’s Therapies Show Similar Safety

Large claims analysis finds no significant differences in serious infections, blood clots, or major cardiovascular events across biologics and a Janus kinase inhibitor.

• by Doug Brunk

• February 19, 2026

• 2 min

GLP-1 and GLP-2 as intestinal reparative therapies in inflammatory bowel disease: mechanisms, translation, and clinical opportunity

• by Joseph J. Lee, Pratikiran Bajgain, Amy L. Lightner

• May 18, 2026

Side Effects: Four Studies Worth Passing On

Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.

• by Kerri Miller

• April 9, 2026

• 6 min